Invitados extranjeros

Keith J. Barrington
Professor of Paediatrics at the University of Montreal.
Neonatologist and clinical researcher at Sainte Justine University Health Center in Montreal.
Ex Chair of the Society of Neonatologists of Quebec.
Research interests are in cardiovascular support, in apnea and its treatment, in the ethics of decision making for high risk newborns


--------------------------------------------------------

 Teresa Boone 
(USA)

-------------------------------------------------------

Teresa Murguía 
(Universidad Panamericana México DF, México)

--------------------------------------------------------

David Edwards
Director of the Centre for the Developing Brain.
Professor of Paediatrics and Neonatal Medicine, and Head of the Department of Perinatal Imaging and Health, King’s College London.
Consultant Neonatologist, Evelina Children’s Hospital.
Fellow of the Academy of Medical Sciences.
Visiting Professor in the Department of Bioengineeing, Imperial College.
Research interests: 
The aim of the Centre for the Developing Brain is to reduce the incidence and severity of neurological impairment caused by problems around the time of birth.
They investigate the mechanisms of perinatal brain injury in order to find effective therapies, and have developed the first successful treatment for birth asphyxia, hypothermic neural rescue therapy.


                                                     --------------------------------------------------------

Annie Janvier
Associate Professor, Department of Pediatrics, University of Montreal.
Neonatologist and Clinical Researcher, Neonatal Intensive Care Unit, Centre
Hospitalier Universitaire Sainte-Justine.
Member, Clinical Ethics Unit, Centre Hospitalier Universitaire Sainte-Justine.
Co-director, Microprogram and Master's in Pediatric Clinical Ethics, University of Montreal.
As a neonatologist, Dr. Annie Janvier works first hand with patients and families confronted with difficult decisions such as withholding or withdrawing therapy and end-of-life issues.


--------------------------------------------------------

Paolo Manzoni 
Torino, Italia

--------------------------------------------------------

Camilia Martin
Department of Medicine Research. Division of Newborn Medicine Research.
Assistant Professor of Pediatrics, Harvard Medical School.
Associate Director of the Neonatal Intensive Care Unit.
Director for Cross-Disciplinary Research Partnerships in the Division of Translational Research. Beth Israel Deaconess Medical Center, Boston, MA.
Fellowship in Perinatal-Neonatal Medicine at the Harvard Combined Program in Neonatology.
Masters in Epidemiology at Harvard School of Public Health.
Research interests
Neonatal nutrition and its impact on health and disease in the preterm infant.
Growth and long-term neurodevelopmental outcomes in the extremely preterm infant.
Her current research focus is on fat digestion and fatty acid metabolism, postnatal intestinal adaptation, development of local and systemic immune defenses, and regulation of the inflammatory response.


--------------------------------------------------------

Andrés Maturana
Pediatrician and Nneonatologist.
Head of the Department of Neonatology. Clínica Alemana.
Master in Health Methodology. Department of Clinical Epidemiology.
Mc Master University. Canada.
Tutor in Evidence Based Medicine.
Fellowship de Medical Education (FAIMER).
Research interests in respiratory pathophysiology.


--------------------------------------------------------

Octavio Ramilo

Nationwide Children’s Hospital and the Ohio State University, Columbus, Ohio, USA.

Octavio Ramilo is the Henry G. Cramblett Chair in Medicine and Professor of Pediatrics at the Ohio State University College of Medicine, and Chief of the Division of Infectious Diseases at Nationwide Children’s Hospital in Columbus, Ohio. He obtained his medical degree from the Universidad Complutense in Madrid, Spain. Dr.Ramilo completed his pediatric residency at the Hospital “12 de Octubre” in Madrid and a subsequent Pediatric Infectious Disease Fellowship at the University of Texas Southwestern Medical Center in Dallas, Texas.

 He has been involved in translational and clinical research related to the role of the host immune response in pathogenesis of infectious diseases for over 25 years. His current research is focused on pathogenesis and treatment of respiratory infections, especially RSV, and the application of genomics and system analysis approaches for improving diagnosis and understanding of host responses to infectious agents and vaccines.


--------------------------------------------------------

Marco Safadi 
Santa Casa, San Pablo, Brasil

--------------------------------------------------------

Pablo Sánchez 
Universidad de Ohio, Columbus, USA

Pablo J. Sánchez is a neonatologist and pediatric infectious diseases specialist, with a longstanding interest in clinical and translational research focused on perinatal and neonatal infections. 

He earned his medical degree at the University of Pittsburgh School of Medicine in 1981, as well as a fellowship in Neonatal-Perinatal Medicine from Columbia-Presbyterian Medical Center, New York, in 1986 and a fellowship in pediatric infectious disease from the University of Texas Southwestern (UTSW) Medical Center, Dallas, in 1988.

 

Dr. Sánchez is Professor of Pediatrics at Nationwide Children’s Hospital - The Ohio State University (OSU), Divisions of Neonatal-Perinatal Medicine and Pediatric Infectious Diseases, since August, 2013.  Previously, he was on faculty at UTSW Medical Center for 25 years.

 

He is the principal investigator (PI) the National Institute of Child Health and Human Development (NICHD) Neonatal Research Network (NRN) at Nationwide Children’s Hospital – OSU. Previously, he served in that capacity while at UTSW from 2006-2013.  He also served as the Dallas site PI for the National Institutes of Health National Institute on Deafness and Other Communication Disorders CHIMES study on congenital CMV screening and natural history of hearing loss in these infants and children. He is a member of the University of Alabama’s Collaborative Antiviral study Group (CASG) and has participated in studies on congenital CMV, neonatal herpes, enterovirus, and influenza (oseltamivir). He is aleading authority on congenital syphilis and has been an invited participant for the Centers for Disease Control and Prevention STD Treatment Guidelines on Congenital Syphilis. He has authored and co-authored more than 100 peer-reviewed publications and book chapters. 


--------------------------------------------------------

María Schiaratura 
Columbia Hospital, USA

--------------------------------------------------------

Renato Stein 
Pontificia Universidad Católica, Porto Alegre, Brasil